These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2049813)

  • 1. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives.
    Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and antihypertensive activity of 1,4-dihydropyridine derivatives with a 4-(disubstituted phenyl) ring and an aminoalkyl ester group: highly potent and long-lasting calcium antagonists.
    Kanno H; Yamaguchi H; Okamiya Y; Sunakawa K; Takeshita T; Naruchi T
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2049-54. PubMed ID: 1423758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 1,4-dihydropyridine calcium antagonists. I. Synthesis and hypotensive activity of 4-(substituted pyridyl)-1,4-dihydropyridine derivatives.
    Ashimori A; Ono T; Uchida T; Ohtaki Y; Fukaya C; Watanabe M; Yokoyama K
    Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2446-58. PubMed ID: 2285975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological effects of optically active 2-[4-(4-benzhydryl-1-piperazinyl)phenyl]-ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate hydrochloride.
    Ashimori A; Uchida T; Ohtaki Y; Tanaka M; Ohe K; Fukaya C; Watanabe M; Kagitani M; Yokoyama K
    Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):108-11. PubMed ID: 2049794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel 2-amino-1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having N,N-dialkylaminoalkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Nishino S; Fujihara Y; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):797-817. PubMed ID: 7553967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel 2-amino-1,4-dihydropyridine calcium antagonists. I. Synthesis and antihypertensive effects of 2-amino-1,4-dihydropyridine derivatives having nitroxy-alkoxycarbonyl groups at 3- and/or 5-position.
    Kobayashi T; Inoue T; Kita Z; Yoshiya H; Nishino S; Oizumi K; Kimura T
    Chem Pharm Bull (Tokyo); 1995 May; 43(5):788-96. PubMed ID: 7553966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1,4-dihydropyridine-5-phosphonates and their calcium-antagonistic and antihypertensive activities: novel calcium-antagonist 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate hydrochloride ethanol (NZ-105) and its crystal structure.
    Sakoda R; Kamikawaji Y; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2362-9. PubMed ID: 1446356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The new generation dihydropyridine type calcium blockers, bearing 4-phenyl oxypropanolamine, display alpha-/beta-adrenoceptor antagonist and long-acting antihypertensive activities.
    Liang JC; Yeh JL; Wang CS; Liou SF; Tsai CH; Chen IJ
    Bioorg Med Chem; 2002 Mar; 10(3):719-30. PubMed ID: 11814861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antihypertensive activities of 1,4-dihydropyridine-5-phosphonate derivatives. I.
    Morita I; Tada S; Kunimoto K; Tsuda M; Kise M; Kimura K
    Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3898-904. PubMed ID: 3435985
    [No Abstract]   [Full Text] [Related]  

  • 10. Antihypertensive effect of the novel water-soluble calcium antagonist (+/-)-3-(4-allyl-1-piperazinyl)-2,2-dimethylpropyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate dihydrochloride in rats.
    Wada K; Nakamura S; Morishita S; Kanda M; Matsui H; Fukata F; Shirahase H
    Arzneimittelforschung; 1994 Oct; 44(10):1112-6. PubMed ID: 7818582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and crystal structure of optically active 2-[benzyl(phenyl)amino]ethyl 5-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphorinan-2-yl)-1,4-dihydro-2,6-dim ethyl-4-(3-nitrophenyl)-3-pyridinecarboxylate (NZ-105).
    Sakoda R; Matsumoto H; Seto K
    Chem Pharm Bull (Tokyo); 1992 Sep; 40(9):2377-81. PubMed ID: 1446358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative QSAR studies of two series of 1,4-dihydropyridines as slow calcium channel blockers.
    Wikel JH; Bemis KG; Kurz K; Denney ML; Main BW; Moore RA; Smith T; Shingleton L; Holland DR
    Drug Des Discov; 1994 Jan; 11(1):1-14. PubMed ID: 8068815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and biological activities of optical isomers of 2-(4-diphenylmethyl-1-piperazinyl)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate (manidipine) dihydrochloride.
    Kajino M; Wada Y; Nagai Y; Nagaoka A; Meguro K
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2225-8. PubMed ID: 2598325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological activities of new 1,4-benzothiazine derivatives.
    Kajino M; Mizuno K; Tawada H; Shibouta Y; Nishikawa K; Meguro K
    Chem Pharm Bull (Tokyo); 1991 Nov; 39(11):2888-95. PubMed ID: 1799937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antihypertensive activities of new 1,4-dihydropyridine containing nitroimidazolyl substituent with a nitrooxy group at the 3-ester position.
    Shafiee A; Rastkary N; Jorjani M; Shafaghi B
    Arch Pharm (Weinheim); 2002 Mar; 335(2-3):69-76. PubMed ID: 12043457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permanently charged chiral 1,4-dihydropyridines: molecular probes of L-type calcium channels. Synthesis and pharmacological characterization of methyl(omega-trimethylalkylammonium) 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylate iodide, calcium channel antagonists.
    Peri R; Padmanabhan S; Rutledge A; Singh S; Triggle DJ
    J Med Chem; 2000 Jul; 43(15):2906-14. PubMed ID: 10956198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive effects of MPC-1304, a novel calcium antagonist, in experimental hypertensive rats and dogs.
    Kanda A; Haruno A; Miyake H; Nagasaka M
    J Cardiovasc Pharmacol; 1992; 20(5):723-30. PubMed ID: 1280733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological activity of stereoisomers of 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 1-(phenylmethyl)-3-piperidinyl ester.
    Muto K; Kuroda T; Kawato H; Karasawa A; Kubo K; Nakamizo N
    Arzneimittelforschung; 1988 Nov; 38(11A):1662-5. PubMed ID: 3219137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of a new class of 1,4-dihydropyridines having a hydroxamic ester group in position 3 with a potential calcium antagonistic activity.
    Inglesi M; Nicola M; Magnetti S
    Farmaco; 1990 Dec; 45(12):1327-40. PubMed ID: 2090142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.